nach oben

Drugs & Aging

Erschienen in:

01.01.2009 | Review Article

Pharmacists’ Interventions for Optimization of Medication Use in Nursing Homes

A Systematic Review

verfasst von: Charlotte L. R. Verrue, Prof. Dr Mirko Petrovic, Els Mehuys, Jean Paul Remon, Robert Vander Stichele

Erschienen in: Drugs & Aging | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

The elderly use more medications than younger adults. In addition, the prevalence of inappropriate prescribing is high in nursing homes. The aim of this review was to collect and interpret the results of clinical studies of interventions involving pharmacists aimed at improving the quality of prescribing in nursing homes, and to identify the key elements for a successful intervention. To this end, we searched MEDLINE, International Pharmaceutical Abstracts and EMBASE from January 1987 to May 2008. Studies were selected that (i) involved a pharmacist; (ii) took place in the nursing home setting; (iii) involved residents aged ≥65 years; (iv) included residents with a range of diseases (not targeted at a specific pathology); (v) were controlled trials (randomized or not). The search strategy retrieved eight controlled studies that fitted the inclusion criteria. A meta-analysis was not possible because of the difference in outcomes chosen in the publications. We found mixed evidence for the effectiveness of various interventions by pharmacists on pharmacotherapy in the nursing home setting. Pharmacists can have different roles in the nursing home such as performing regular medication reviews, being an active member of a multidisciplinary team and/or educating physicians, nurses and other nursing home staff about medication use. Our review shows that the available evidence is mixed concerning the effectiveness of interventions by pharmacists on pharmacotherapy in the nursing home setting. At the same time, greater pharmacist involvement has been shown in published studies to increase physicians’ and nurses’ knowledge and awareness about medication. Evidence is scarce, however, and there is a need for large, well conducted randomized controlled trials in the nursing home setting. Attention should be paid to the choice of outcome measures and to multidisciplinary collaboration when assessing the effects of pharmacists’ interventions on medication use in nursing homes.

Jones D, Poole C. Medicine taking by elderly people: an overview. In: George CF, Woodhouse KW, editors. Drug therapy in old age. Chichester, UK: Wiley and Sons, 1998: 1–22

Walley T, Scott AK. Prescribing in the elderly. Postgrad Med J 1995; 71(838): 466–71PubMedPubMedCentral

Lau DT, Kasper JD, Potter DE, et al. Hospitalisation and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005; 165: 68–74PubMed

Perri M, Menon AM, Deshpande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005; 39(3): 405–11PubMed

Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117(8): 684–9PubMed

Schmader KE, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994; 42(12): 1241–7PubMed

Gupta S, Rappaport HM, Bennett LT. Inappropriate drug prescribing and related outcomes for elderly Medicaid beneficiaries residing in nursing homes. Clin Ther 1996; 18(1): 183–96PubMed

Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272(4): 292–6PubMed

Aparasu RR, Sitzman SJ. Inappropriate prescribing for the elderly in the outpatient department setting. Am J Health-Syst Pharm 1999; 56(5): 433–9PubMed

10.

Levenson SA, Saffel DA. The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success. J Med Dir 2007; 8(1): 55–64

11.

Furniss L, Craig SKL, Burns A. Medication use in nursing homes for elderly people. Int J Geriatr Psychiatr 1998; 13(7): 433–9

12.

Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging 2005; 22(7): 559–69PubMed

13.

Stoudemire A, Smith DA. OBRA regulations and the use of psychotropic drugs in long-term care facilities: impact and implications for geropsychiatric care. Gen Hosp Psychiatry 1996; 18(2): 77–94PubMed

14.

Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990; 38(5): 542–52PubMed

15.

Kaldy J. Teacher, teacher: when pharmacists embrace their role as educators. Consult Pharm 2008; 23(2): 100–102, 105-106, 109-10PubMed

16.

Linnebur SA, O’Connell MB, Wessell AM, et al. Pharmacy practice, research, education, and advocacy for older adults. Pharmacotherapy 2005; 25(10): 1396–430PubMed

17.

Cameron KA. Preventing medication-related problems among older Americans. Manag Care Interface 1998; 11(10): 74–76, 78, 83-5PubMed

18.

Harjivan C, Lyles A. Improved medication use in long-term care: building on the consultant pharmacist’s drug regimen review. Am J Manag Care 2002; 8(4): 318–26PubMed

19.

Bootman JL, Harrison DL, Cox ER. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997; 157(18): 2089–96PubMed

20.

Daschner M, Brownstein S, Cameron KA, et al. Fleetwood phase II tests a new model of long-term care pharmacy. Consult Pharm 2000; 15(10): 989–1005

21.

Christian JB, van Haaren A, Cameron KA, et al. Alternatives for potentially inappropriate medications in the elderly population: treatment algorithms for use in the Fleetwood Phase III study. Consult Pharm 2004; 19(11): 1011–28PubMed

22.

Lapane KL, Hiris J, Hughes CM, et al. Development and implementation of pharmaceutical care planning software for nursing homes based on the Fleetwood Model. Am J Health Syst Pharm 2006; 63(24): 2483–7PubMed

23.

Roughead EE, Semple SJ, Gilbert AL. Quality use of medicines in aged-care facilities in Australia. Drugs Aging 2003; 20(9): 643–53PubMed

24.

Klepping G. Medication review in elderly care homes. Prim Care Pharm 2000; 1(4): 105–8

25.

Schmidt I, Claesson CB, Westerholm B, et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46(1): 77–82PubMed

26.

Schmidt IK, Claesson CB, Westerholm B, et al. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998; 32(1): 27–32PubMed

27.

Furniss L, Burns A, Craig SKL, et al. Effects of a pharmacist’s medication review in nursing homes: randomised controlled trial. Br J Psychiatry 2000; 176: 563–7PubMed

28.

Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001; 51(3): 257–65PubMedPubMedCentral

29.

Crotty M, Whitehead C, Rowett D, et al. An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res 2004; 4(1): 6PubMedPubMedCentral

30.

Crotty M, Halbert J, Rowett D, et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33(6): 612–7PubMed

31.

Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2(4): 257–64PubMed

32.

Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006; 35(6): 586–91PubMed

33.

King MA, Roberts MS. Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci 2001; 23(2): 41–5PubMed

34.

Majumdar SR, Soumerai SB. Why most interventions to improve physician prescribing do not seem to work. Can Med Assoc J 2003; 169(1): 30–1

35.

Handler SM, Wright RM, Ruby CM, et al. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother 2006; 4(3): 264–72PubMed

36.

Nester TM, Hale LS. Effectiveness of a pharmacist-acquired medication history in promoting patient safety. Am J Health-Syst Pharm 2002; 59(22): 2221–5PubMed

37.

Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 2002; 22(2): 134–47PubMed

38.

Al-Rashed SA, Wright DJ, Roebuck N, et al. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002; 54(6): 657–64PubMedPubMedCentral

39.

Boddy C. Pharmacist involvement with warfarin dosing for inpatients. Pharm World Sci 2001; 23(1): 31–5PubMed

40.

Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health-Syst Pharm 2002; 59(21): 2089–92PubMed

41.

Kucukarslan SN, Peters M, Mlynarek M, et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003; 163(17): 2014–8PubMed

42.

Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 1999; 19(5): 556–64PubMed

43.

Mol PGM, Wieringa JE, NannanPanday PV, et al. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother 2005; 55(4): 550–7PubMed

44.

Schiller DS. Identification, management, and prevention of adverse effects associated with highly active antiretroviral therapy. Am J Health-Syst Pharm 2004; 61(23): 2507–22PubMed

45.

Krishnan HS, Schaefer M. Evaluation of the impact of pharmacist’s advice giving on the outcomes of self-medication in patients suffering from dyspepsia. Pharm World Sci 2000; 22(3): 102–8PubMed

46.

Buurma H, De Smet P, Leufkens HGM, et al. Evaluation of the clinical value of pharmacists’ modifications of prescription errors. Br J Clin Pharmacol 2004; 58(5): 503–11PubMedPubMedCentral

47.

Hawksworth GM, Corlett AJ, Wright DJ, et al. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999; 47(6): 695–700PubMedPubMedCentral

48.

Chabot I, Moisan J, Gregoire JP, et al. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003; 37(9): 1186–93PubMed

49.

Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004; 38(11): 1954–60PubMed

50.

MacLaughlin EJ, MacLaughlin AA, Snella KA, et al. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy 2005; 25(3): 379–86PubMed

51.

Jaber LA, Halapy H, Fernet M, et al. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996; 30(3): 238–43PubMed

52.

Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 1997; 17(6): 1274–85PubMed

53.

Erickson SR, Slaughter R, Halapy H. Pharmacists’ ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997; 17(1): 140–7PubMed

54.

Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998; 38(5): 574–85

55.

Cowper PA, Weinberger M, Hanlon JT, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 1998; 18(2): 327–32PubMed

56.

Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy 2000; 20(12): 1508–16PubMed

Titel: Pharmacists’ Interventions for Optimization of Medication Use in Nursing Homes
A Systematic Review
verfasst von: Charlotte L. R. Verrue
Prof. Dr Mirko Petrovic
Els Mehuys
Jean Paul Remon
Robert Vander Stichele
Publikationsdatum: 01.01.2009
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 1/2009
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.2165/0002512-200926010-00003

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Olmesartan Medoxomil in Elderly Patients with Essential or Isolated Systolic Hypertension

Self-Medication in Older Urban Mexicans

Factors Associated with Bleeding in Elderly Hospitalized Patients Treated with Enoxaparin Sodium

Modulation of Human Peripheral Blood Mononuclear Cell Proliferative Response by Diltiazem

Complexities of Diagnosis and Treatment of Allergic Respiratory Disease in the Elderly